AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 420

First Page		Document Content
Date: 2014-10-06 14:04:09 Chemistry Pharmacology HIV/AIDS Fixed dose combination Emtricitabine Reverse-transcriptase inhibitor Antiretroviral drug Bristol-Myers Squibb Tenofovir/emtricitabine Gilead Sciences Organofluorides Medicine		AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 420 Add to Reading List Source URL: www.aidsinfonet.org Download Document from Source Website File Size: 88,34 KB Share Document on Facebook

	KEI request for investigation into anticompetitive aspects of Gilead Voluntary Licenses for patents on Tenofivir and Emtricitabine 12 February 2007 Federal Trade Commission Washington, DC Attn: Randy Marks DocID: 1umkN - View Document
	AIDS InfoNetwww.aidsinfonet.org Fact Sheet Number 478 Biktarvy (bictegravir + emtricitabine + tenofovir alafenamide) DocID: 1ucKl - View Document
	Pre-Exposure Prophylaxis (PrEP): A primer for primary care providers Daily emtricitabine/tenofovir (Truvada®) is safe and effective for reducing the risk of HIV acquisition in sexually active men and women and injection DocID: 1rPaA - View Document
	PrEPARING FOR THE END OF HIV? How to access PrEP in Contra Costa County… For Insured Folks: Private Medical Provider-Most health insurance companies cover Truvada (emtricitabine and tenofovir disoproxil fumarate, the m DocID: 1rAVd - View Document
	Trans and Gender Non-Conforming (TGNC) Folks and PrEP: WHAT WE SHOULD KNOW DocID: 1reG7 - View Document